Tag Archives: flatfunding

MSF Report:Growing HIV Treatment Crisis in Africa

By on .

What does flat funding for PEPFAR and other global AIDS programs mean on the ground in places like the Democratic Republic of Congo? Fewer new treatment slots. Uncertainty about access to lifesaving drugs. An unfolding crisis. That’s one snippet in a bigger, disturbing picture painted by a new report from Doctors Without Borders, or MSF. […]

A Unique Perspective on Flat-Funding From a Clinician, Activist, and HIV-Positive Woman

By on .

Lydia Mungherera knows better than most people what’s at stake in the unfolding crisis over global AIDS funding. She is a medical doctor, an activist, and woman living with AIDS, and she’s growing increasingly concerned about the ramifications of flat-funding for the President’s Emergency Plan for AIDS Relief, a cornerstone of the international response to […]

New Goosby Interview Highlights Challenges, Next Steps in Global AIDS

By on .

President Obama’s US Global AIDS Coordinator, Eric Goobsy, MD, discusses health system strengthening, PEPFAR’s tight budget, the Administration’s Global Health Initiative, and other subjects in this interview posted on the Global Health Council’s blog. It’s definitely worth reading for the latest insights into the Administration’s plans for battling global AIDS.

Ramifications of a Retreat on HIV/AIDS

By on .

A new report out today from Doctors Without Borders (Medecins Sans Frontieres) highlights concerns that donor countries’ commitment to combating the deadly HIV/AIDS epidemic is wavering. “MSF teams working to treat HIV/AIDS are witnessing worrying signs of waning international support to combat HIV/AIDS,” the report says. “In some high-burden countries, patients are being turned away […]

Global TB & HIV–The Promise and Perils Ahead

By on .

Physicians on the front lines of the global tuberculosis epidemic have faced an uphill battle against this deadly scourge, especially with the rise of virulent new drug-resistant strands of this ancient germ and outmoded drugs and diagnostics. But the medical landscape for TB could change dramatically in the coming years—with new tests and better drugs […]